U.S. Life Sciences Stock News

Summit Therapeutics (SMMT) is back in the spotlight after positive phase 3 data for its lead drug ivonescimab in non small cell lung cancer, which is sharpening focus on the stock’s long term setup. See our latest analysis for Summit Therapeutics. The latest phase 3 win comes after a huge multi year run, with a three year total shareholder return of 448.62 percent. However, a modest 1 year total shareholder return of negative 4.42 percent suggests momentum has cooled near 17.94 dollars as...

Etsy (ETSY) just posted a quarter where revenue grew 2% year over year and both sales and EBITDA beat expectations, yet the stock has slid sharply since the report, leaving investors reassessing the setup. See our latest analysis for Etsy. The market reaction fits into a choppy picture, with a 30 day share price return of minus 14.14 percent and a one year total shareholder return of minus 6.57 percent. This underscores fading momentum despite modest year to date gains. If Etsy’s latest swing...

Wondering if Roper Technologies is quietly turning into a value opportunity while everyone is distracted by flashier tech names? You are not alone, and that is exactly what we are going to unpack here. Despite being a high quality software and technology conglomerate, the stock has slipped, down about 0.8% over the last week, 1.7% over the last month, and 13.9% year to date, leaving it roughly 19.1% lower than a year ago even though 5 year returns are still positive at 8.1%. Recent moves...

Wondering if PagSeguro Digital at around $10 a share is still a bargain or if the easy money has already been made? This breakdown is designed to help you figure out where the value really sits. Despite slipping 2.8% over the last week, the stock is still up 1.5% over the past month, 57.3% year to date and 51.4% over the last year, even after a tough 5 year stretch where it is still down 80.7% from earlier highs. Recent moves have been shaped by shifting sentiment around Brazilian fintechs,...

Phreesia (PHR) just posted its latest quarterly scorecard with Q2 2026 revenue of about $117 million and basic EPS of $0.01, setting a clearer snapshot of where the business stands on its path toward profitability. The company has seen revenue move from roughly $102 million in Q2 2025 to $117 million in Q2 2026, while quarterly EPS has shifted from a loss of about $0.31 to a modest profit, giving investors fresh data on how quickly margins might be stabilizing from here. See our full analysis...

Brown & Brown (BRO) has quietly slipped this year, with the stock down around 23% year to date even as the business continues to post double digit revenue and earnings growth. So what is the market missing? See our latest analysis for Brown & Brown. The recent slide in Brown & Brown’s share price, with a roughly 23% year to date share price decline to around $77.51, contrasts sharply with a solid three year total shareholder return of about 36%. This suggests long term momentum remains intact...

Recent coverage around UMB Financial (UMBF) has focused on its steady net interest income growth and faster climbing earnings, drawing renewed attention from investors who are reassessing what they are willing to pay for the stock. See our latest analysis for UMB Financial. That stronger earnings story seems to be filtering into the market, with a 1 month share price return of 7.86 percent lifting UMB Financial to 118.43 dollars. This comes even though the 1 year total shareholder return is...

Dow Inc. recently completed a partnership with Macquarie, selling a 49% stake in certain U.S. Gulf Coast infrastructure assets for about US$3.00 billion, while also tightening capital expenditure and reporting gains in its Industrial Intermediates & Infrastructure segment in Q3 2025. This combination of a large cash inflow, sharper spending discipline, and improving segment performance highlights Dow’s focus on strengthening its balance sheet and refocusing on higher-return operations. We’ll...

In recent days, Americold Realty Trust reaffirmed its full-year 2025 financial outlook at the Nareit REITworld conference, where its CEO and CFO met investors and highlighted the company’s global temperature-controlled logistics footprint of more than 230 facilities. This confirmation of guidance, alongside commentary on warehouse segment revenue and net operating income trends, offers investors clearer visibility into near-term fundamentals for a business already controlling a large share...

WESCO International, Inc. is refreshing its board with two new independent directors, Michael L. Carter and David C. Wajsgras, a governance move that could subtly shape strategy and capital allocation over time. See our latest analysis for WESCO International. The board refresh comes as WESCO’s $276.98 share price sits on the back of a strong run, with a 90 day share price return of 25.61 percent and a five year total shareholder return of 272.01 percent suggesting momentum is still very much...

Wondering if Compañía de Minas BuenaventuraA is still good value after its big run, or if you might be late to the party, you are not alone. The stock has climbed 6.5% over the last week, 15.0% over the past month, and is up an eye catching 121.7% year to date, with a 105.4% gain over the last year and 256.0% over three years. These moves have come as investors have refocused on precious metals names and Latin American miners amid shifting expectations for interest rates and safe haven...

Earlier this week, Korn Ferry reported past fiscal second-quarter 2026 results, with revenue rising to US$729.8 million and diluted EPS from continuing operations improving to US$1.36, while also issuing fiscal third-quarter guidance for revenue of US$680 million to US$694 million and diluted EPS of US$1.15 to US$1.21. The company also maintained its quarterly dividend at US$0.48 per share and highlighted growing Executive Search and RPO activity, underlining continued demand across its...

If you want to compound wealth in the stock market, you can do so by buying an index fund. But if you pick the right...

Wondering if Bank of America is still worth buying after its big run, or if you are late to the party? This breakdown will help you decide whether the current price stacks up to the underlying value. From a recent close of $54.08, the stock is up 22.1% year to date and 112.5% over 5 years. This signals that investors have been steadily re-rating the bank despite a flatter 7-day performance and a modest 1-month move of 1.2%. That strength has come as markets have priced in a more resilient US...

ATI Inc. has announced that longtime executive James Robert "Rob" Foster will become Senior Vice President, Finance and Chief Financial Officer on January 1, 2026, succeeding current CFO Don Newman, who will move into a Strategic Advisor role before retiring on March 1, 2026. The choice of an internal leader with both deep operational experience and prior finance leadership signals ATI’s emphasis on tying capital decisions closely to manufacturing performance and long-term contract...

Fortive (FTV) jumped after its Q3 report showed revenue and earnings coming in ahead of expectations, giving investors a reason to revisit a stock that has lagged the broader tech space. See our latest analysis for Fortive. At around $54.80, Fortive’s one month share price return of 6.76 percent and 90 day share price return of 10.55 percent hint at improving momentum. This is the case even though the year to date share price return remains sharply negative and the one year total shareholder...

General American Investors Company, Inc. recently renewed its preferred stock repurchase program, authorizing further buybacks of its 5.95% Cumulative Preferred Stock, Series B, while President and CEO Jeffrey W. Priest purchased 60 shares of this preferred issue on December 8, 2025. Together, the renewed buyback authorization and insider purchase highlight management’s emphasis on capital structure management and alignment with preferred shareholders’ interests. Next, we will examine how...

If you are wondering whether OUTFRONT Media is still a bargain after its run up, or if you have missed the bus, this breakdown will help you assess whether the current price really makes sense. The stock has quietly delivered a 1.6% gain over the last week and 12.9% over the last month. It is now up 31.8% year to date, with a 31.2% gain over the past year hinting that investors are warming up to its story. Investor interest has been driven by a mix of strategic moves in its transit and...

Pool (POOL) just delivered Q3 2025 results that back up the stabilization story investors have been waiting for, with building materials revenue finally growing year over year and margins moving higher. See our latest analysis for Pool. The stock has been under pressure for most of the year, with a roughly 27.7 percent year to date share price decline and a 33.8 percent drop in one year total shareholder return. However, today’s post earnings bounce hints that sentiment may be starting to...

Lattice Semiconductor (LSCC) just rolled out a fresh 250 million dollar share repurchase program, a clear signal that management sees value in the current share price and future earnings power. See our latest analysis for Lattice Semiconductor. That confidence backed by the new buyback comes after a strong run, with the share price at 78.41 dollars and a year to date share price return of just over 40 percent. The 1 year total shareholder return above 25 percent suggests momentum is still...

If you are wondering whether Elevance Health at around $341 a share is a bargain hiding in plain sight or a value trap in slow motion, you are not alone. This is exactly the kind of stock where valuation really matters. Over the last month the stock has climbed about 12.3%, including a 3.1% gain in just the past week, even though it is still down 6.8% year to date and about 9.8% over the last year after a tougher three-year stretch. That turnaround in momentum has come as investors refocus...

In recent days, analysts have highlighted CubeSmart’s improving self-storage fundamentals, pointing to stabilizing market rents, raised guidance, and strengthening trends in key urban markets such as New York City. The contrasting analyst opinions, with some citing muted self-storage demand while others name CubeSmart a top recovery idea for 2026, underscore how sensitive the company’s outlook is to shifts in sector pricing and occupancy. Next, we’ll examine how RBC’s emphasis on CubeSmart’s...

If you are wondering whether Crescent Energy is a quietly mispriced energy play or a value trap in the making, you are not alone. This breakdown aims to cut through the noise. Despite trading around $9.76, the stock has climbed 0.6% over the last week and 8.9% over the past month, even though it is still down 34.4% year to date and 30.5% over the last year. Much of this recent bounce has come as investors rotate back into select energy names and reassess companies with scale, cash flow and...

If you have ever wondered whether Colgate Palmolive is quietly becoming a bargain while markets chase flashier names, you are exactly the kind of investor this breakdown is for. The stock has drifted lower, with shares at around $77.76 and returns of 5.2% over 3 years and just 2.9% over 5 years. This hints at subdued expectations rather than runaway optimism. Recently, investor attention has focused on Colgate Palmolive's push into higher margin premium oral care products and its broader...